EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-7.88%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
-$29.7M
(-2.7%)
Cap. Flow
+$88.7M
Cap. Flow
% of AUM
8.26%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15
Top Buys
| 1 |
TSMC
TSM
|
+$29.5M |
| 2 |
Grab
GRAB
|
+$28.9M |
| 3 |
Qualcomm
QCOM
|
+$21.2M |
| 4 |
Advanced Micro Devices
AMD
|
+$16.3M |
| 5 |
Sea Limited
SE
|
+$14.7M |
Top Sells
| 1 |
Mercado Libre
MELI
|
+$25.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$13.4M |
| 3 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
+$6.5M |
| 4 |
IMAB
I-MAB
IMAB
|
+$1.24M |
| 5 |
ProShares Ultra Gold
UGL
|
+$1.01M |
Sector Composition
| 1 | Consumer Discretionary | 34.29% |
| 2 | Technology | 26.19% |
| 3 | Communication Services | 11.91% |
| 4 | Healthcare | 11.24% |
| 5 | Real Estate | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Linde
LIN
$223B
| $269K | 0.03% |
996
-4
| -0.4% | -$1.08K |
|
252
Skyworks Solutions
SWKS
$11.2B
| $269K | 0.03% |
3,149
-76
| -2% | -$6.49K |
|
253
Kura Oncology
KURA
$707M
| $265K | 0.02% |
19,380
+8,807
| +83% | +$120K |
|
254
Agios Pharmaceuticals
AGIO
$2.12B
| $264K | 0.02% |
9,340
-4,333
| -32% | -$122K |
|
255
Altimmune
ALT
$327M
| $264K | 0.02% |
+20,640
| New | +$264K |
|
256
ConocoPhillips
COP
$114B
| $262K | 0.02% |
2,559
-14
| -0.5% | -$1.43K |
|
257
Philip Morris
PM
$253B
| $261K | 0.02% |
3,139
+61
| +2% | +$5.07K |
|
|
DCPH
258
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $257K | 0.02% |
13,887
-4,066
| -23% | -$75.2K |
|
259
Zoetis
ZTS
$67.3B
| $256K | 0.02% |
1,725
+180
| +12% | +$26.7K |
|
260
Baidu
BIDU
$37.4B
| $254K | 0.02% |
2,166
+102
| +5% | +$12K |
|
261
Datadog
DDOG
$47.6B
| $254K | 0.02% |
2,866
+163
| +6% | +$14.4K |
|
262
Humana
HUM
$37.3B
| $254K | 0.02% |
523
+49
| +10% | +$23.8K |
|
263
Karyopharm Therapeutics
KPTI
$54.2M
| $251K | 0.02% |
3,062
-449
| -13% | -$36.8K |
|
264
Krystal Biotech
KRYS
$4.2B
| $250K | 0.02% |
3,591
-217
| -6% | -$15.1K |
|
265
Stryker
SYK
$150B
| $250K | 0.02% |
1,232
+108
| +10% | +$21.9K |
|
266
Rocket Pharmaceuticals
RCKT
$352M
| $249K | 0.02% |
+15,578
| New | +$249K |
|
267
Lowe's Companies
LOW
$153B
| $246K | 0.02% |
1,308
-5
| -0.4% | -$940 |
|
268
Syndax Pharmaceuticals
SNDX
$1.41B
| $242K | 0.02% |
+10,064
| New | +$242K |
|
269
Union Pacific
UNP
$129B
| $242K | 0.02% |
1,243
-4
| -0.3% | -$779 |
|
270
RTX Corp
RTX
$206B
| $241K | 0.02% |
2,943
-10
| -0.3% | -$819 |
|
271
United Parcel Service
UPS
$71.5B
| $239K | 0.02% |
1,482
+23
| +2% | +$3.71K |
|
272
eBay
EBAY
$42.5B
| $238K | 0.02% |
6,459
| – | – |
|
273
Becton Dickinson
BDX
$54.9B
| $237K | 0.02% |
1,062
+99
| +10% | +$22.1K |
|
274
Ocugen
OCGN
$322M
| $237K | 0.02% |
132,938
-25,946
| -16% | -$46.3K |
|
275
PMV Pharmaceuticals
PMVP
$74.2M
| $237K | 0.02% |
19,884
-7,617
| -28% | -$90.8K |
|